Latest filing published 30 Sept 2025 for 昭衍新药, €84k.
孙云霞 (board member) discloses dealings in 昭衍新药 to SSE / SZSE (CSRC). Over a trading history stretching from 3 November 2023 to 30 September 2025, the count stands at 3 filings.
The open-market record consists of 3 sales worth €1.3M, with no purchase. Since January 2025: no purchases and 1 sale on the market.
The record was last updated on 30 September 2025 with an open-market sale (€84k) in 昭衍新药. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.